
Olmiswift HA 12.5mg/20mg Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Hydrochlorothiazide (12.5mg) + Olmesartan Medoxomil (20mg)
Overview Olmiswift HA 12.5mg/20mg Tablet
HCTZ/Olmesartan 12.5mg/20mg tablets combine two active ingredients to manage hypertension through complementary mechanisms. Untreated hypertension significantly elevates the risk of serious complications including stroke, myocardial infarction, and renal failure. This medication can be taken with or without food; dosage is individualized based on patient response and condition, ideally at the same time daily for optimal efficacy. Continuous use, as directed by your physician, is crucial for blood pressure control. The formulation includes a diuretic, increasing urinary output; therefore, avoid administration within four hours of bedtime. Consistent use is beneficial even during asymptomatic periods; discontinuation may increase the risk of cardiovascular events. Dizziness is a frequently reported side effect; others include fatigue, cephalalgia, chest discomfort, muscle weakness, and fluid retention (edema). Increased urination is expected due to the diuretic component and is not considered an adverse reaction. While infrequent, more serious side effects are possible, including potentially irreversible ocular hypertension if not promptly addressed. Consult the accompanying patient information leaflet and report any concerning or persistent side effects to your doctor; dosage adjustment or alternative treatment may be considered. This medication is contraindicated during pregnancy and lactation. Individuals with pre-existing hepatic or renal impairment, cardiac disease, or diabetes should seek medical advice prior to initiating therapy. Concurrent alcohol consumption may potentiate hypotensive effects and increase adverse reactions.
Uses of Olmiswift HA 12.5mg/20mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmiswift HA 12.5mg/20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmiswift HA 12.5mg/20mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Olmiswift HA 12.5mg/20mg Tablet:
- Dizziness
- Weakness
- Tiredness
- Edema (swelling)
- Chest pain
- Upper respiratory tract infection
- Headache
- Increased triglyceride level in blood
- Increased uric acid level in blood
- Abdominal pain
- Back pain
- Skeletal pain
- Blood in urine
- Increased liver enzymes
- Increased blood urea
How to use Olmiswift HA 12.5mg/20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Olmiswift HA 12.5mg/20mg Tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, although consistent timing is recommended.
How Olmiswift HA 12.5mg/20mg Tablet works:
Each Olmiswift HA 12.5mg/20mg tablet contains a dual-action formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmiswift HA 12.5mg/20mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Olmiswift HA 12.5mg/20mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Olmiswift HA 12.5mg/20mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Olmiswift HA 12.5mg/20mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmiswift HA 12.5mg/20mg tablets. Dosage modification of Olmiswift HA 12.5mg/20mg tablets may be necessary. Physician consultation is recommended. Routine blood pressure checks are suggested to guide dosage changes.
LiverCAUTION
Patients with liver impairment should use Olmiswift HA 12.5mg/20mg tablets cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised.
What if you forget to take Olmiswift HA 12.5mg/20mg Tablet :
Should you forget a dose of Olmiswift HA 12.5mg/20mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmiswift HA 12.5mg/20mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
